High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
Clinical trial NCT05943691 · UNKNOWN
Trial details
- NCT number
- NCT05943691
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2024-07-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.